Articles tagged with: additional monitoring
Latuda-lurasidone
Latuda-lurasidone
Package leaflet: Information for the patient
Latuda® 18.5 mg film-coated tablets; Latuda® 37 mg film-coated tablets; Latuda® 74 mg film-coated tablets
This medicine is subject to additional monitoring. This will allow quick identification of new safety …
Depakote Tablets
Depakote Tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER
Depakote® 250mg and 500mg Tablets
Valproic acid (as valproate semisodium)
Is this leaflet hard to see or read?
Phone 0845 372 7101 for help
▼ This medicine is subject to additional monitoring. This …
Elvanse 20-70 mg (Lisdexamfetamine dimesylate)
Elvanse 20-70 mg (Lisdexamfetamine dimesylate)
Package leaflet: Information for the user
Elvanse 20 mg capsules, hard; Elvanse 30 mg capsules, hard; Elvanse 40 mg capsules, hard; Elvanse 50 mg capsules, hard; Elvanse 60 mg capsules, hard; Elvanse …
